Document:

<PAGE>
                                                                     EXHIBIT 4.2

THIS NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933. THEY MAY NOT BE SOLD, OFFERED FOR
SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1993, OR AN OPINION
OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER
SUCH ACT OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SUCH ACT.

                           CONVERTIBLE PROMISSORY NOTE

[$_____________]                                                  August 7, 2001

FOR VALUE RECEIVED, the undersigned, THE PLASTIC SURGERY COMPANY, a Georgia
corporation ("MAKER"), promises to pay to the order of [Insert Name of Lender]
("PAYEE", the "PAYEE" and any subsequent holder(s) hereof are hereinafter
referred to collectively as "HOLDER"), in lawful money of the United States of
America at the office of Payee at [Insert Address of Holder], or at such other
place as Holder may designate to Maker in writing from time to time, the
principal sum of [Insert Amount of Loan], together with interest on the
outstanding principal balance hereof from the date hereof at the Base Rate (as
such term is defined with respect to the Payee in the Loan Agreement, dated as
of even date herewith, by and between Maker, Payee and certain other lenders set
forth on the signature pages thereto (the "LOAN AGREEMENT")). All interest
hereunder shall be calculated based on a 360-day year and paid for the actual
number of days elapsed. Capitalized terms used herein and not otherwise defined
shall have the meaning ascribed to such terms in the Loan Agreement. Interest
only on the outstanding principal balance hereof shall be due and payable
monthly, in arrears, with the first installment being payable on the last
Business Day of the 1st full calendar month next succeeding the Closing Date,
and subsequent installments being payable on the last Business Day of each
succeeding month thereafter until the Maturity Date. The principal balance and
all accrued but unpaid interest hereunder shall be payable on the Maturity Date.

Notwithstanding anything to the contrary contained in this Note or in the Loan
Agreement, Holder shall have the right, upon written demand (the "Demand") at
any time after the closing of a PIPE Transaction within twelve months of the
date hereof, to accelerate Maker's obligation to pay all principal and accrued
interest hereunder (such payment, the "Demand Payment"). The Demand Payment
shall be due and payable ten (10) days after Holder delivers the Demand to the
Maker. For purposes of this Note, a "PIPE Transaction" shall mean the closing of
a private investment in public equity transaction with aggregate offering
proceeds to Maker in excess of four million dollars ($4,000,000), excluding any
conversion of debt into equity. The indebtedness evidenced hereby may be prepaid
in whole or in part, at any time and from time to time, provided that (a) Maker
shall make no prepayment under the Notes in an aggregate amount less than
$25,000 and (b) Maker otherwise complies with the terms and conditions of the
Loan Agreement in connection with such partial or complete prepayment. Any such
prepayments shall be credited first to any accrued and unpaid interest and then
to the outstanding principal balance hereof.

This Note will be a fully-registered note on the books of Maker and will be
issued only in fully-registered form. Maker will cause to be kept at its
principal office a register for the registration and transfer of the Notes. The
name and address of each Holder hereof, the transfer thereof and the names and
addresses of any transferee hereof, or any interest therein, shall be recorded
in such register. Until a transfer hereof is duly registered on the books of
Maker, Maker may treat the registered Holder thereof as the owner for all

                                       1
<PAGE>

purposes. This Note is subject to the restrictions on transfer set forth herein
and in the Loan Agreement.

Time is of the essence of this Note. It is hereby expressly agreed that in the
event that any default be made in the payment of principal or interest as
stipulated above, which default is not cured following the giving of any
applicable notice and within five (5) business days; or in the event that any
Default or Event of Default shall occur under the Loan Agreement, which Default
or Event of Default is not cured following the giving of any applicable notice
and within any applicable cure period set forth in said Loan Agreement; or
should any default by Maker be made in the performance or observance of any
covenants or conditions contained in any other instrument or document now or
hereafter evidencing, securing or otherwise relating to the indebtedness
evidenced hereby (subject to any applicable notice and cure period provisions
that may be set forth therein); then, and in such event, the entire outstanding
principal balance of the indebtedness evidenced hereby, together with any other
sums advanced hereunder, under the Loan Agreement and/or under any other
instrument or document now or hereafter evidencing, securing or in any way
relating to the indebtedness evidenced hereby, together with all unpaid interest
accrued thereon, shall, at the option of Holder and without notice to Maker, at
once become due and payable and may be collected forthwith, regardless of the
stipulated date of maturity. Upon the occurrence of any default as set forth
herein, at the option of Holder and without notice to Maker, all accrued and
unpaid interest, if any, shall be added to the outstanding principal balance
hereof, and the entire outstanding principal balance, as so adjusted, shall bear
interest thereafter at the Post-Default Rate until the Default is cured,
regardless of whether or not there has been an acceleration of the payment of
principal as set forth herein. All such interest shall be paid at the time of
and as a condition precedent to the curing of any such default.

The outstanding principal and interest on this Note may be converted into shares
of Common Stock of the Maker as follows:

         ELECTION TO CONVERT. THE OUTSTANDING AGGREGATE PRINCIPAL AMOUNT OF THIS
NOTE PLUS ALL ACCRUED BUT UNPAID INTEREST HEREUNDER SHALL BE, AT THE ELECTION OF
HOLDER, CONVERTED INTO THAT NUMBER OF SHARES OF COMMON STOCK OF MAKER DETERMINED
BY DIVIDING (I) THE SUM OF SUCH OUTSTANDING AGGREGATE PRINCIPAL AMOUNT PLUS ALL
ACCRUED AND UNPAID INTEREST ON THE CONVERSION DATE (AS DEFINED BELOW) BY (II)
THE PURCHASE PRICE (AS DEFINED IN AND ADJUSTED FROM TIME TO TIME IN ACCORDANCE
WITH THAT CERTAIN WARRANT TO PURCHASE [INSERT NUMBER OF SHARES] SHARES OF COMMON
STOCK OF MAKER, ISSUED BY MAKER TO PAYEE IN CONNECTION WITH THE EXECUTION AND
DELIVERY OF THIS NOTE).

         MECHANICS OF CONVERSION. IN CONNECTION WITH SUCH CONVERSION OF THIS
NOTE, THE HOLDER SHALL SURRENDER THIS NOTE, DULY ENDORSED, AT THE PRINCIPAL
OFFICE OF THE MAKER (THE DATE OF RECEIPT BY MAKER OF SUCH NOTICE HEREINAFTER
REFERRED TO AS THE "CONVERSION DATE"). AT ITS EXPENSE, MAKER SHALL, AS SOON AS
PRACTICABLE THEREAFTER, ISSUE AND DELIVER TO THE HOLDER AT THE OFFICE OF HOLDER
(AS SET FORTH IN THE FIRST PARAGRAPH HEREOF) A CERTIFICATE OR CERTIFICATES FOR
THE COMMON STOCK (BEARING SUCH LEGENDS AS MAY BE REQUIRED OR ADVISABLE IN THE
OPINION OF COUNSEL TO THE COMPANY), TOGETHER WITH A CHECK PAYABLE TO THE HOLDER
FOR ANY CASH AMOUNTS PAYABLE AS DESCRIBED IN SECTION (C) BELOW.

         NO FRACTIONAL SHARES. NO FRACTIONAL SHARES SHALL BE ISSUED UPON
CONVERSION OF THIS NOTE. IN LIEU OF THE MAKER ISSUING ANY FRACTIONAL SHARES TO
THE HOLDER UPON THE CONVERSION OF THIS NOTE, THE MAKER SHALL PAY TO THE HOLDER
AN AMOUNT IN CASH EQUAL TO THE PRODUCT OBTAINED BY MULTIPLYING THE PURCHASE
PRICE BY THE FRACTION OF A SHARE NOT ISSUED PURSUANT TO THE PREVIOUS SENTENCE.
UPON CONVERSION OF THIS NOTE IN FULL AND THE PAYMENT OF THE AMOUNTS SPECIFIED IN
THIS NOTE, THE MAKER SHALL BE RELEASED FROM ALL ITS OBLIGATIONS AND LIABILITIES
UNDER THIS NOTE.

In the event this Note is placed in the hands of an attorney for collection, or
if Holder incurs any costs incident to the collection of the indebtedness
evidenced hereby, Maker and any indorsers hereof agree to pay to Holder an
amount equal to all such costs, including without limitation all actual
reasonable attorney's fees and all court costs.

Presentment for payment, demand, protest and notice of demand, protest and
nonpayment are hereby waived by Maker and all other parties hereto. No failure
to accelerate the indebtedness evidenced hereby by reason of default hereunder,
acceptance of a past-due installment or other indulgences granted from time to
time, shall be construed as a novation of this Note or as a waiver of such right
of acceleration or of the right of Holder thereafter to insist upon strict
compliance with the terms of this Note or to prevent the exercise of such right
of acceleration or any other right granted hereunder or by applicable laws. No

                                       2
<PAGE>

extension of the time for payment of the indebtedness evidenced hereby or any
installment due hereunder, made by agreement with any person now or hereafter
liable for payment of the indebtedness evidenced hereby, shall operate to
release, discharge, modify, change or affect the original liability of Maker
hereunder or that of any other person now or hereafter liable for payment of the
indebtedness evidenced hereby, either in whole or in part, unless Holder agrees
otherwise in writing. This Note may not be changed orally, but only by an
agreement in writing signed by the party against whom enforcement of any waiver,
change, modification or discharge is sought.

The indebtedness and other obligations evidenced by this Note are further
evidenced by (i) the Loan Agreement and (ii) certain other instruments and
documents as may be required to protect and preserve the rights of Maker and
Payee as more specifically described in the Loan Agreement. Reference is made to
the Loan Agreement and the other "Loan Documents" referred to therein for a
complete statement of the rights and obligations of Borrower and the holder of
this Note. Among other items, the Loan Agreement sets forth the circumstances
under which unpaid principal and interest under this Note may or must be prepaid
or become due and payable prior to the scheduled due dates thereof and the
circumstances under which interest hereunder shall be calculated at the
Post-Default Rate. All agreements herein made are expressly limited so that in
no event whatsoever, whether by reason of advancement of proceeds hereof,
acceleration of maturity of the unpaid balance hereof or otherwise, shall the
amount paid or agreed to be paid to Holder for the use of the money advanced or
to be advanced hereunder exceed the maximum rate of interest allowed by law (the
"MAXIMUM RATE"). If, from any circumstances whatsoever, the fulfillment of any
provision of this Note or any other agreement or instrument now or hereafter
evidencing, securing or in any way relating to the indebtedness evidenced hereby
shall involve the payment of interest in excess of the Maximum Rate, then, ipso
facto the obligation to pay interest hereunder shall be reduced to the Maximum
Rate; and if from any circumstance whatsoever, Holder shall ever receive
interest, the amount of which would exceed the amount collectible at the Maximum
Rate, such amount as would be excessive interest shall be applied to the
reduction of the principal balance remaining unpaid hereunder and not to the
payment of interest. This provision shall control every other provision in any
and all other agreements and instruments existing or hereafter arising between
Maker and Holder with respect to the indebtedness evidenced hereby.

This Note is intended as a contract under and shall be construed and enforceable
in accordance with the laws of the State of California, except to the extent
that federal law may be applicable to the determination of the Maximum Rate.

                                   MAKER:
                                   THE PLASTIC SURGERY COMPANY
                                   A GEORGIA CORPORATION

                                   By:
                                   ---------------------------------------------
                                   Title:

                                       3<PAGE>
                                                                     EXHIBIT 4.3

                                     WARRANT
THE WARRANT EVIDENCED OR CONSTITUTED HEREBY, AND ALL SHARES OF COMMON STOCK
ISSUABLE HEREUNDER, HAVE BEEN AND WILL BE ISSUED WITHOUT REGISTRATION UNDER THE
SECURITIES ACT OF 1933, AS AMENDED ("THE ACT") AND MAY NOT BE SOLD, OFFERED FOR
SALE, TRANSFERRED, PLEDGED OR HYPOTHECATED WITHOUT REGISTRATION UNDER THE ACT
UNLESS EITHER (I) THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL, IN FORM AND
SUBSTANCE REASONABLY SATISFACTORY TO THE COMPANY, TO THE EFFECT THAT
REGISTRATION IS NOT REQUIRED IN CONNECTION WITH SUCH DISPOSITION OR (II) THE
SALE OF SUCH SECURITIES IS MADE PURSUANT TO SECURITIES AND EXCHANGE COMMISSION
RULE 144.

WARRANT TO PURCHASE COMMON STOCK OF THE PLASTIC SURGERY COMPANY
                             (Subject to Adjustment)
NO.___________
THIS CERTIFIES THAT, for value received, [Insert Name of Lender], or its
permitted registered assigns ("Holder"), is entitled, subject to the terms and
conditions of this warrant, at any time or from time to time after the date of
issuance hereof and before the expiration date specified in Section 2.7 (the
"Expiration Date"), to purchase from The Plastic Surgery Company, a Georgia
Corporation, (the "Company"), [Insert Number of Shares] shares of Warrant Stock
(as defined in Section 1 below) of the Company at a price per share equal to the
Purchase Price (as defined in Section 1 below). Both the number of shares of
Warrant Stock purchasable upon exercise of this Warrant and the Purchase Price
are subject to adjustment and change as provided herein. This Warrant is issued
in connection with that certain Loan Agreement, dated as of August 7, 2001, (the
"Agreement"), by and between the Company, Holder and certain other lenders set
forth on the signature pages thereto.

                                       1
<PAGE>

    CERTAIN DEFINITIONS. AS USED IN THIS WARRANT THE FOLLOWING TERMS SHALL HAVE
THE FOLLOWING RESPECTIVE MEANINGS:
    "FAIR MARKET VALUE" OF A SHARE OF COMMON STOCK AS OF A PARTICULAR DATE SHALL
MEAN:
    IF TRADED ON A SECURITIES EXCHANGE OR THE NASDAQ NATIONAL MARKET, THE FAIR
MARKET VALUE SHALL BE DEEMED TO BE THE AVERAGE OF THE CLOSING PRICES OF THE
COMMON STOCK OF THE COMPANY ON SUCH EXCHANGE OR MARKET OVER THE 5 BUSINESS DAYS
ENDING IMMEDIATELY PRIOR TO THE APPLICABLE DATE OF VALUATION;
    IF ACTIVELY TRADED OVER-THE-COUNTER, THE FAIR MARKET VALUE SHALL BE DEEMED
TO BE THE AVERAGE OF THE CLOSING BID PRICES OVER THE 30-DAY PERIOD ENDING
IMMEDIATELY PRIOR TO THE APPLICABLE DATE OF VALUATION; AND
    IF THERE IS NO ACTIVE PUBLIC MARKET, THE FAIR MARKET VALUE SHALL BE THE
VALUE THEREOF, AS DETERMINED IN GOOD FAITH BY THE COMPANY'S BOARD OF DIRECTORS;
PROVIDED, HOWEVER, THAT IF THE HOLDER OBJECTS IN GOOD FAITH TO SUCH
DETERMINATION, THEN SUCH VALUE SHALL BE DETERMINED BY AN INDEPENDENT VALUATION
FIRM EXPERIENCED IN VALUING BUSINESSES SUCH AS THAT OF THE COMPANY AND JOINTLY
SELECTED IN GOOD FAITH BY THE COMPANY AND THE HOLDER. FEES AND EXPENSES OF THE
VALUATION FIRM SHALL BE SHARED EQUALLY BY THE COMPANY AND THE HOLDER.
    IF THE COMPANY HAS ENTERED INTO AN AGREEMENT OR HAS RECEIVED A BINDING
LETTER OF INTENT FOR A PROPOSED ACQUISITION TRANSACTION (AS SUCH TERM IS DEFINED
IN SECTION 5.6 HEREOF), THE FAIR MARKET VALUE SHALL BE THE PRICE PER SHARE OF
THE COMMON STOCK IN THE ACQUISITION TRANSACTION, REGARDLESS OF WHETHER SUCH
TRANSACTION HAS BEEN PUBLICLY ANNOUNCED OR CONSUMMATED. WHENEVER THE
CONSIDERATION TO BE PAID IN ANY ACQUISITION TRANSACTION IS ASSETS OTHER THAN
CASH OR SECURITIES, THE VALUE THEREOF SHALL BE DETERMINED IN GOOD FAITH BY THE
COMPANY'S BOARD OF DIRECTORS; PROVIDED, HOWEVER, THAT IF THE HOLDER OBJECTS IN
GOOD FAITH TO SUCH DETERMINATION, THEN SUCH VALUE SHALL BE DETERMINED BY AN
INDEPENDENT VALUATION FIRM EXPERIENCED IN VALUING BUSINESSES SUCH AS THAT OF THE
COMPANY AND JOINTLY SELECTED IN GOOD FAITH BY THE COMPANY AND THE HOLDER. FEES
AND EXPENSES OF THE VALUATION FIRM SHALL BE SHARED EQUALLY BY THE COMPANY AND
THE HOLDER. IF THE CONSIDERATION TO BE PAID IN ANY ACQUISITION TRANSACTION IS
SECURITIES, THE VALUE OF SUCH SECURITIES SHALL BE DETERMINED IN SUBSTANTIALLY
THE SAME MANNER USED TO DETERMINE THE VALUE OF THE COMPANY'S COMMON STOCK SET
FORTH IN SECTION 1.1(A), (B) AND (C) ABOVE.
"HSR Act" shall mean the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
"Purchase Price" shall be $1.00 per share.
"Registered Holder" shall mean any Holder in whose name this Warrant is
registered upon the books and records maintained by the Company.
"Warrant" as used herein, shall include this Warrant and any warrant delivered
in substitution or exchange therefor as provided herein.
"Warrant Stock" shall mean the Common Stock of the Company and any other
securities at any time receivable or issuable upon exercise of this Warrant.
    EXERCISE OF WARRANT
    PAYMENT. Subject to compliance with the terms and conditions of this Warrant
  and applicable securities laws, this Warrant may be exercised, in whole or in
  part at any time or from time to time, on or before the Expiration Date by the
  delivery (including, without limitation, delivery by facsimile) of the form of
  Notice of Exercise attached hereto as EXHIBIT 1 (the "Notice of Exercise"),
  duly executed by the Holder, at the principal office of the Company, and as
  soon as practicable after such date, surrendering this Warrant at the
  principal office of the Company, and payment, (i) in cash (by check) or by
  wire transfer, (ii) by cancellation of any outstanding debt and/or accrued
  interest owing by the Company to the Holder, including amounts owing under the
  Notes (as defined in the Agreement and in that certain Loan Agreement, dated
  as of December 18, 2000, by and between Company and Holder, as amended by the
  Amendment No. 1 to December 2000 Loan Agreement, date as of August 7, 2001
  (the "December Loan Agreement")); (iii) by exchange of the Company's
  securities held by Holder, at the Fair Market Value thereof or (iv) by a
  combination of (i), (ii) and (iii), of an amount equal to the product obtained
  by multiplying the number of shares of Warrant Stock being purchased upon such
  exercise by the then effective Purchase Price (the "Exercise Amount"), except
  that if Holder is subject to HSR Act Restrictions (as defined in Section 2.5
  below), the Exercise Amount shall be paid to the Company within five (5)
  business days of the termination of all HSR Act Restrictions.

                                       2
<PAGE>

    NET ISSUE EXERCISE. In lieu of the payment methods set forth in Section
  2.1(b) above, the Holder may elect to exchange all or some of the Warrant for
  shares of Warrant Stock equal to the value of the amount of the Warrant being
  exchanged on the date of exchange. If Holder elects to exchange this Warrant
  as provided in this Section 2.2, Holder shall tender to the Company the
  Warrant for the amount being exchanged, along with written notice of Holder's
  election to exchange some or all of the Warrant, and the Company shall issue
  to Holder the number of shares of Warrant Stock computed using the following
  formula:

                              X     =      Y (A-B)
                                           -------
                                         A
         Where X = the number of shares of Warrant Stock to be issued to Holder.
         Y = the number of shares of Warrant Stock purchasable under the amount
         of the Warrant being exchanged (as adjusted to the date of such
         calculation).
         A = the Fair Market Value of one share of the Company's Common Stock.
         B = Purchase Price (as adjusted to the date of such calculation).

All references herein to an "exercise" of the Warrant shall include an exchange
pursuant to this Section 2.2.
    "EASY SALE" EXERCISE. In lieu of the payment methods set forth in Section
  2.1(b) above, when permitted by law and applicable regulations (including the
  American Stock Exchange and NASD rules), the Holder may pay the Purchase Price
  through a "same day sale" commitment from the Holder (and if applicable a
  broker-dealer that is a member of the National Association of Securities
  Dealers (a "NASD Dealer")), whereby the Holder irrevocably elects to exercise
  this Warrant and to sell a portion of the Shares so purchased to pay for the
  Purchase Price and the NASD Dealer commits upon receipt of such Shares to
  forward the Purchase Price directly to the Company.
    STOCK CERTIFICATES; FRACTIONAL SHARES. As soon as practicable on or after
  such date, the Company shall issue and deliver to the person or persons
  entitled to receive the same a certificate or certificates for the number of
  whole shares of Common Stock issuable upon such exercise, together with cash
  in lieu of any fraction of a share equal to such fraction of the current Fair
  Market Value of one whole share of Common Stock as of the date of exercise of
  this Warrant. No fractional shares or scrip representing fractional shares
  shall be issued upon an exercise of this Warrant.
    HSR ACT. The Company hereby acknowledges that exercise of this Warrant by
  Holder may subject the Company and/or the Holder to the filing requirements of
  the HSR Act and that Holder may be prevented from exercising this Warrant
  until the expiration or early termination of all waiting periods imposed by
  the HSR Act ("HSR Act Restrictions"). If on or before the Expiration Date
  Holder has sent the Notice of Exercise to Company and Holder has not been able
  to complete the exercise of this Warrant prior to the Expiration Date because
  of HSR Act Restrictions, the Holder shall be entitled to complete the process
  of exercising this Warrant in accordance with the procedures contained herein
  notwithstanding the fact that completion of the exercise of this Warrant would
  take place after the Expiration Date.
    PARTIAL EXERCISE; EFFECTIVE DATE OF EXERCISE. In case of any partial
  exercise of this Warrant, the Company shall cancel this Warrant upon surrender
  hereof and shall execute and deliver a new Warrant of like tenor and date for
  the balance of the shares of Warrant Stock purchasable hereunder. Any partial
  exercise of this Warrant, other than the final exercise, shall be for a
  minimum of one thousand (1,000) shares of Warrant Stock. This Warrant shall be
  deemed to have been exercised immediately prior to the close of business on
  the date of its surrender for exercise as provided above together with the
  payment of the exercise price pursuant to Sections 2.1, 2.2 and 2.3 hereof.
  However, if Holder is subject to HSR Act filing requirements this Warrant
  shall be deemed to have been exercised on the date immediately following the
  date of the expiration of all HSR Act Restrictions. The person entitled to
  receive the shares of Warrant Stock issuable upon exercise of this Warrant
  shall be treated for all purposes as the holder of record of such shares as of
  the close of business on the date the Holder is deemed to have exercised this
  Warrant.
    EXPIRATION DATE; NOTICE OF EXPIRATION. The Company shall deliver to Holder a
  written Notice of Expiration in the form attached hereto as Exhibit 2 at least
  thirty (30) days but not more than sixty (60) days before the Expiration Date.
  Subject to Section 5.6 hereof, this Warrant shall expire on the earliest to
  occur of the following: (i) the tenth (10th) anniversary of the date of
  issuance hereof or (ii) the sixth (6th) anniversary of the date of repayment

                                       3
<PAGE>

  in full of the Note issued contemporaneously herewith pursuant to the
  Agreement (the "Expiration Date"); provided, however, that the Expiration Date
  shall be extended until the date thirty (30) days after delivery of the Notice
  of Expiration.
    VALID ISSUANCE; TAXES. ALL SHARES OF WARRANT STOCK ISSUED UPON THE EXERCISE
OF THIS WARRANT SHALL BE VALIDLY ISSUED, FULLY PAID AND NON-ASSESSABLE, AND THE
COMPANY SHALL PAY ALL TAXES AND OTHER GOVERNMENTAL CHARGES THAT MAY BE IMPOSED
IN RESPECT OF THE ISSUE OR DELIVERY THEREOF. THE COMPANY SHALL NOT BE REQUIRED
TO PAY ANY TAX OR OTHER CHARGE IMPOSED IN CONNECTION WITH ANY TRANSFER INVOLVED
IN THE ISSUANCE OF ANY CERTIFICATE FOR SHARES OF WARRANT STOCK IN ANY NAME OTHER
THAN THAT OF THE REGISTERED HOLDER OF THIS WARRANT, AND IN SUCH CASE THE COMPANY
SHALL NOT BE REQUIRED TO ISSUE OR DELIVER ANY STOCK CERTIFICATE OR SECURITY
UNTIL SUCH TAX OR OTHER CHARGE HAS BEEN PAID, OR IT HAS BEEN ESTABLISHED TO THE
COMPANY'S REASONABLE SATISFACTION THAT NO TAX OR OTHER CHARGE IS DUE.
    ANTIDILUTION. IF DURING THE TWELVE MONTH PERIOD FOLLOWING THE DATE HEREOF
COMPANY ISSUES ADDITIONAL SHARES OF COMMON STOCK ("ADDITIONAL COMMON STOCK"),
INCLUDING BUT NOT LIMITED TO THE COMPANY'S ISSUANCE OF SHARES OF COMMON STOCK AS
IN KIND PAYMENT FOR ANY PRINCIPAL OR INTEREST PAYABLE ON ANY OR ALL OF THE
COMPANY'S DEBT OBLIGATIONS, AT A PRICE PER SHARE LESS THAN THE PURCHASE PRICE
(AS ADJUSTED PURSUANT TO THE TERMS AND CONDITIONS CONTAINED HEREIN), THE
PURCHASE PRICE SHALL BE REDUCED CONCURRENTLY WITH SUCH ISSUE, TO A PRICE EQUAL
TO THE PRICE FOR ONE SHARE OF SUCH ADDITIONAL COMMON STOCK. AS USED HEREIN,
ADDITIONAL COMMON STOCK SHALL EXCLUDE THE FOLLOWING SHARES OF COMMON STOCK
ISSUED OR ISSUABLE: (I) TO OFFICERS, DIRECTORS OR EMPLOYEES OF, OR CONSULTANTS
TO, THE COMPANY PURSUANT TO STOCK OPTION OR STOCK PURCHASE PLANS OR AGREEMENTS
ON TERMS APPROVED BY THE COMPANY'S BOARD OF DIRECTORS, PROVIDED THAT SHARES OF
COMMON STOCK OF THE COMPANY ISSUED PURSUANT TO THIS SECTION 4(I) SHALL NOT AT
ANY TIME CONSTITUTE MORE THAN TWENTY PERCENT (20%) OF THE ISSUED AND OUTSTANDING
CAPITAL STOCK OF THE COMPANY ON A FULLY DILUTED BASIS; (II) UPON EXERCISE OR
CONVERSION OF OPTIONS OR WARRANTS OUTSTANDING AS OF THE DATE HEREOF; (III) IN
CONNECTION WITH THE ACQUISITION BY THE COMPANY OF ANOTHER PERSON BY WAY OF
MERGER, STOCK PURCHASE OR PURCHASE OF ALL OR SUBSTANTIALLY ALL OF THE ASSETS OF
SUCH PERSON; AND (IV) RELATED TO WARRANTS ISSUED TO ANY LESSOR OF CAPITAL
EQUIPMENT OR ANY LENDER OF BORROWED MONIES PURSUANT TO FINANCING ARRANGEMENTS
WITH SUCH LESSOR OR LENDER APPROVED BY THE BOARD OF DIRECTORS OF THE COMPANY.
    ADJUSTMENT OF PURCHASE PRICE AND NUMBER OF SHARES. THE NUMBER OF SHARES OF
WARRANT STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT (OR ANY SHARES OF STOCK OR
OTHER SECURITIES OR PROPERTY RECEIVABLE OR ISSUABLE UPON EXERCISE OF THIS
WARRANT) AND THE PURCHASE PRICE ARE SUBJECT TO ADJUSTMENT UPON OCCURRENCE OF THE
FOLLOWING EVENTS:
   ADJUSTMENT FOR STOCK SPLITS, STOCK SUBDIVISIONS OR COMBINATIONS OF SHARES.
   The Purchase Price of this Warrant shall be proportionally decreased and the
   number of shares of Warrant Stock issuable upon exercise of this Warrant (or
   any shares of stock or other securities at the time issuable upon exercise of
   this Warrant) shall be proportionally increased to reflect any stock split or
   subdivision of the Company's Common Stock. The Purchase Price of this Warrant
   shall be proportionally increased and the number of shares of Warrant Stock
   issuable upon exercise of this Warrant (or any shares of stock or other
   securities at the time issuable upon exercise of this Warrant) shall be
   proportionally decreased to reflect any combination of the Company's Common
   Stock.
   ADJUSTMENT FOR DIVIDENDS OR DISTRIBUTIONS OF STOCK OR OTHER SECURITIES OR
   PROPERTY. In case the Company shall make or issue, or shall fix a record date
   for the determination of eligible holders entitled to receive, a dividend or
   other distribution with respect to the Common Stock (or any shares of stock
   or other securities at the time issuable upon exercise of the Warrant)
   payable in (a) securities of the Company or (b) assets (excluding cash
   dividends paid or payable solely out of retained earnings), then, in each
   such case, the Holder of this Warrant on exercise hereof at any time after
   the consummation, effective date or record date of such dividend or other
   distribution, shall receive, in addition to the shares of Warrant Stock (or
   such other stock or securities) issuable on such exercise prior to such date,
   and without the payment of additional consideration therefor, the securities
   or such other assets of the Company to which such Holder would have been
   entitled upon such date if such Holder had exercised this Warrant on the date
   hereof and had thereafter, during the period from the date hereof to and
   including the date of such exercise, retained such shares and/or all other
   additional stock available by it as aforesaid during such period giving
   effect to all adjustments called for by this Section 5.

                                       4
<PAGE>

   RECLASSIFICATION. If the Company, by reclassification of securities or
   otherwise, shall change any of the securities as to which purchase rights
   under this Warrant exist into the same or a different number of securities of
   any other class or classes, this Warrant shall thereafter represent the right
   to acquire such number and kind of securities as would have been issuable as
   the result of such change with respect to the securities that were subject to
   the purchase rights under this Warrant immediately prior to such
   reclassification or other change and the Purchase Price therefore shall be
   appropriately adjusted, all subject to further adjustment as provided in this
   Section 5. No adjustment shall be made pursuant to this Section 5.3 upon any
   conversion or redemption of the Common Stock which is the subject of Section
   5.5 below.
   ADJUSTMENT FOR CAPITAL REORGANIZATION. In case of any capital reorganization
   of the capital stock of the Company (other than a combination,
   reclassification, exchange or subdivision of shares otherwise provided for
   herein), then, as a part of such reorganization, lawful provision shall be
   made so that the Holder of this Warrant shall thereafter be entitled to
   receive upon exercise of this Warrant, during the period specified herein and
   upon payment of the Purchase Price then in effect, the number of shares of
   stock or other securities or property of the successor corporation resulting
   from such reorganization that a holder of the shares deliverable upon
   exercise of this Warrant would have been entitled to receive in such
   reorganization, if this Warrant had been exercised immediately before such
   reorganization, all subject to further adjustment as provided in this Section
   5. The foregoing provisions of this Section 5.4 shall similarly apply to
   successive reorganizations and to the stock or securities of any other
   corporation that are at the time receivable upon the exercise of this
   Warrant. If the per-share consideration payable to the Holder hereof for
   shares in connection with any such transaction is in a form other than cash
   or marketable securities, then the value of such consideration shall be
   determined in good faith by the Company's Board of Directors. In all events,
   appropriate adjustment (as determined in good faith by the Company's Board of
   Directors) shall be made in the application of the provisions of this Warrant
   with respect to the rights and interests of the Holder after the transaction,
   to the end that the provisions of this Warrant shall be applicable after that
   event, as near as reasonably may be, in relation to any shares or other
   property deliverable after that event upon exercise of this Warrant.
   CONVERSION OF COMMON STOCK. In case all or any portion of the authorized and
   outstanding shares of Common Stock of the Company are redeemed or converted
   or reclassified into other securities or property pursuant to the Company's
   Articles of Incorporation or otherwise, or the Common Stock otherwise ceases
   to exist, then, in such case, the Holder of this Warrant, upon exercise
   hereof at any time after the date on which the Common Stock is so redeemed or
   converted, reclassified or ceases to exist (the "Termination Date"), shall
   receive, in lieu of the number of shares of Common Stock that would have been
   issuable upon such exercise immediately prior to the Termination Date, the
   securities or property that would have been received if this Warrant had been
   exercised in full and the Common Stock received thereupon had been
   simultaneously converted immediately prior to the Termination Date, all
   subject to further adjustment as provided in this Warrant. Additionally, the
   Purchase Price shall be immediately adjusted to equal the quotient obtained
   by dividing (x) the aggregate Purchase Price of the maximum number of shares
   of Common Stock for which this Warrant was exercisable immediately prior to
   the Termination Date by (y) the number of shares of Common Stock of the
   Company for which this Warrant is exercisable immediately before the
   Termination Date, all subject to further adjustment as provided herein.
   ACQUISITION TRANSACTIONS. Notwithstanding anything to the contrary herein, in
   the event that the Company proposes to enter into (i) a transaction for the
   sale of all or substantially all the assets of the Company, or (ii) the
   closing of the acquisition of the Company by another entity by means of
   merger, consolidation or other transaction or series of related transactions,
   resulting in the exchange of the outstanding shares of the Company's capital
   stock such that the shareholders of the Company prior to such transaction
   own, directly or indirectly, less than 50% of the voting power of the
   surviving entity (collectively, an "Acquisition Transaction"), then the
   Company shall provide to the Holder thirty (30) days' written notice of the
   Acquisition Transaction, which notice shall describe the transaction in
   reasonable detail, including the consideration to be paid for the Company's
   securities by the acquiring entities and the date of the closing of the
   Acquisition Transaction (the "Closing Date"), and the Company shall not

                                       5
<PAGE>

   consummate the Acquisition Transaction(s) until after the expiration of such
   notice period. The Holder shall have the right to exercise this Warrant at
   any time before the Closing Date. If Holder fails to exercise this Warrant
   before the Closing Date, this Warrant shall expire on the Closing Date. In
   addition, if Holder elects to exercise this Warrant and pay the exercise
   price, or any portion thereof, with securities of the Company during any
   period in which the Company has entered into discussions regarding an
   Acquisition Transaction or otherwise has proposed or received a proposal for
   such a transaction (and prior to the delivery of a notice of such transaction
   as set forth above), the Company shall (i) inform Holder of such proposal or
   discussions prior to effectuating such exercise and (ii) give Holder the
   option of terminating or delaying the exercise hereof until an agreement or
   binding commitment regarding such Acquisition Transaction is entered into, if
   any.
    CERTIFICATE AS TO ADJUSTMENTS. IN EACH CASE OF ANY ADJUSTMENT IN THE
PURCHASE PRICE, OR NUMBER OR TYPE OF SHARES ISSUABLE UPON EXERCISE OF THIS
WARRANT, THE CHIEF FINANCIAL OFFICER OR CONTROLLER OF THE COMPANY SHALL COMPUTE
SUCH ADJUSTMENT IN ACCORDANCE WITH THE TERMS OF THIS WARRANT AND PREPARE A
CERTIFICATE SETTING FORTH SUCH ADJUSTMENT AND SHOWING IN DETAIL THE FACTS UPON
WHICH SUCH ADJUSTMENT IS BASED, INCLUDING A STATEMENT OF THE ADJUSTED PURCHASE
PRICE. THE COMPANY SHALL PROMPTLY SEND (BY FACSIMILE AND BY EITHER FIRST CLASS
MAIL, POSTAGE PREPAID OR OVERNIGHT DELIVERY) A COPY OF EACH SUCH CERTIFICATE TO
THE HOLDER.
    LOSS OR MUTILATION. UPON RECEIPT OF EVIDENCE REASONABLY SATISFACTORY TO THE
COMPANY OF THE OWNERSHIP OF AND THE LOSS, THEFT, DESTRUCTION OR MUTILATION OF
THIS WARRANT, AND OF INDEMNITY REASONABLY SATISFACTORY TO IT, AND (IN THE CASE
OF MUTILATION) UPON SURRENDER AND CANCELLATION OF THIS WARRANT, THE COMPANY WILL
EXECUTE AND DELIVER IN LIEU THEREOF A NEW WARRANT OF LIKE TENOR AS THE LOST,
STOLEN, DESTROYED OR MUTILATED WARRANT.
    RESERVATION OF COMMON STOCK. THE COMPANY HEREBY COVENANTS THAT AT ALL TIMES
THERE SHALL BE RESERVED FOR ISSUANCE AND DELIVERY UPON EXERCISE OF THIS WARRANT
SUCH NUMBER OF SHARES OF COMMON STOCK OR OTHER SHARES OF CAPITAL STOCK OF THE
COMPANY AS ARE FROM TIME TO TIME ISSUABLE UPON EXERCISE OF THIS WARRANT AND,
FROM TIME TO TIME, WILL TAKE ALL STEPS NECESSARY TO AMEND ITS ARTICLES OF
INCORPORATION TO PROVIDE SUFFICIENT RESERVES OF SHARES OF COMMON STOCK ISSUABLE
UPON EXERCISE OF THIS WARRANT. ALL SUCH SHARES SHALL BE DULY AUTHORIZED, AND
WHEN ISSUED UPON SUCH EXERCISE, SHALL BE VALIDLY ISSUED, FULLY PAID AND
NON-ASSESSABLE, FREE AND CLEAR OF ALL LIENS, SECURITY INTERESTS, CHARGES AND
OTHER ENCUMBRANCES OR RESTRICTIONS ON SALE AND FREE AND CLEAR OF ALL PREEMPTIVE
RIGHTS, EXCEPT ENCUMBRANCES OR RESTRICTIONS ARISING UNDER FEDERAL OR STATE
SECURITIES LAWS. ISSUANCE OF THIS WARRANT SHALL CONSTITUTE FULL AUTHORITY TO THE
COMPANY'S OFFICERS WHO ARE CHARGED WITH THE DUTY OF EXECUTING STOCK CERTIFICATES
TO EXECUTE AND ISSUE THE NECESSARY CERTIFICATES FOR SHARES OF COMMON STOCK UPON
THE EXERCISE OF THIS WARRANT.
    TRANSFER AND EXCHANGE. SUBJECT TO THE TERMS AND CONDITIONS OF THIS WARRANT
AND COMPLIANCE WITH ALL APPLICABLE SECURITIES LAWS, THIS WARRANT AND ALL RIGHTS
HEREUNDER MAY BE TRANSFERRED TO ANY REGISTERED HOLDER'S PARENT, SUBSIDIARY OR
AFFILIATE, IN WHOLE OR IN PART, ON THE BOOKS OF THE COMPANY MAINTAINED FOR SUCH
PURPOSE AT THE PRINCIPAL OFFICE OF THE COMPANY REFERRED TO ABOVE, BY THE
REGISTERED HOLDER HEREOF IN PERSON, OR BY DULY AUTHORIZED ATTORNEY, UPON
SURRENDER OF THIS WARRANT TOGETHER WITH A PROPERLY ENDORSED FORM OF NOTICE OF
ASSIGNMENT ATTACHED HERETO AS EXHIBIT 3 AND UPON PAYMENT OF ANY NECESSARY
TRANSFER TAX OR OTHER GOVERNMENTAL CHARGE IMPOSED UPON SUCH TRANSFER. UPON ANY
PERMITTED PARTIAL TRANSFER, THE COMPANY WILL ISSUE AND DELIVER TO THE REGISTERED
HOLDER A NEW WARRANT OR WARRANTS WITH RESPECT TO THE SHARES OF WARRANT STOCK NOT
SO TRANSFERRED. EACH TAKER AND HOLDER OF THIS WARRANT, BY TAKING OR HOLDING THE
SAME, CONSENTS AND AGREES THAT WHEN THIS WARRANT SHALL HAVE BEEN SO ENDORSED,
THE PERSON IN POSSESSION OF THIS WARRANT MAY BE TREATED BY THE COMPANY, AND ALL
OTHER PERSONS DEALING WITH THIS WARRANT, AS THE ABSOLUTE OWNER HEREOF FOR ANY
PURPOSE AND AS THE PERSON ENTITLED TO EXERCISE THE RIGHTS REPRESENTED HEREBY,
ANY NOTICE TO THE CONTRARY NOTWITHSTANDING; PROVIDED, HOWEVER THAT UNTIL A
TRANSFER OF THIS WARRANT IS DULY REGISTERED ON THE BOOKS OF THE COMPANY, THE
COMPANY MAY TREAT THE REGISTERED HOLDER HEREOF AS THE OWNER FOR ALL PURPOSES.
    RESTRICTIONS ON TRANSFER. THE HOLDER, BY ACCEPTANCE HEREOF, AGREES THAT,
ABSENT AN EFFECTIVE REGISTRATION STATEMENT FILED WITH THE SEC UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE "1933 ACT"), COVERING THE DISPOSITION OR
SALE OF THIS WARRANT OR THE WARRANT STOCK ISSUED OR ISSUABLE UPON EXERCISE

                                       6
<PAGE>

HEREOF, AS THE CASE MAY BE, AND REGISTRATION OR QUALIFICATION UNDER APPLICABLE
STATE SECURITIES LAWS, SUCH HOLDER WILL NOT SELL, TRANSFER, PLEDGE, OR
HYPOTHECATE ANY OR ALL SUCH WARRANTS OR WARRANT STOCK, AS THE CASE MAY BE,
UNLESS EITHER (I) THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL, IN FORM AND
SUBSTANCE REASONABLY SATISFACTORY TO THE COMPANY, TO THE EFFECT THAT SUCH
REGISTRATION IS NOT REQUIRED IN CONNECTION WITH SUCH DISPOSITION OR (II) THE
SALE OF SUCH SECURITIES IS MADE PURSUANT TO SEC RULE 144.
    COMPLIANCE WITH SECURITIES LAWS. BY ACCEPTANCE OF THIS WARRANT, THE HOLDER
HEREBY REPRESENTS, WARRANTS AND COVENANTS THAT ANY SHARES OF STOCK PURCHASED
UPON EXERCISE OF THIS WARRANT OR ACQUIRED UPON CONVERSION THEREOF SHALL BE
ACQUIRED FOR INVESTMENT ONLY AND NOT WITH A VIEW TO, OR FOR SALE IN CONNECTION
WITH, ANY DISTRIBUTION THEREOF; THAT THE HOLDER HAS HAD SUCH OPPORTUNITY AS SUCH
HOLDER HAS DEEMED ADEQUATE TO OBTAIN FROM REPRESENTATIVES OF THE COMPANY SUCH
INFORMATION AS IS NECESSARY TO PERMIT THE HOLDER TO EVALUATE THE MERITS AND
RISKS OF ITS INVESTMENT IN THE COMPANY; THAT THE HOLDER IS ABLE TO BEAR THE
ECONOMIC RISK OF HOLDING SUCH SHARES AS MAY BE ACQUIRED PURSUANT TO THE EXERCISE
OF THIS WARRANT FOR AN INDEFINITE PERIOD; THAT THE HOLDER UNDERSTANDS THAT THE
SHARES OF STOCK ACQUIRED PURSUANT TO THE EXERCISE OF THIS WARRANT OR ACQUIRED
UPON CONVERSION THEREOF WILL NOT BE REGISTERED UNDER THE 1933 ACT (UNLESS
OTHERWISE REQUIRED PURSUANT TO EXERCISE BY THE HOLDER OF THE REGISTRATION
RIGHTS, IF ANY, GRANTED PREVIOUSLY OR IN CONNECTION HEREWITH TO THE REGISTERED
HOLDER) AND WILL BE "RESTRICTED SECURITIES" WITHIN THE MEANING OF RULE 144 UNDER
THE 1933 ACT AND THAT THE EXEMPTION FROM REGISTRATION UNDER RULE 144 WILL NOT BE
AVAILABLE FOR AT LEAST ONE YEAR FROM THE DATE OF EXERCISE OF THIS WARRANT,
SUBJECT TO ANY SPECIAL TREATMENT BY THE SEC FOR EXERCISE OF THIS WARRANT
PURSUANT TO SECTION 2.2, AND EVEN THEN WILL NOT BE AVAILABLE UNLESS A PUBLIC
MARKET THEN EXISTS FOR THE STOCK, ADEQUATE INFORMATION CONCERNING THE COMPANY IS
THEN AVAILABLE TO THE PUBLIC, AND OTHER TERMS AND CONDITIONS OF RULE 144 ARE
COMPLIED WITH; AND THAT ALL STOCK CERTIFICATES REPRESENTING SHARES OF STOCK
ISSUED TO THE HOLDER UPON EXERCISE OF THIS WARRANT MAY HAVE AFFIXED THERETO A
LEGEND SUBSTANTIALLY IN THE FOLLOWING FORM:

         THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE
         SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR UNDER THE SECURITIES
         LAWS OF ANY STATE. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON
         TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT
         AS PERMITTED UNDER THE ACT AND THE APPLICABLE STATE SECURITIES LAWS,
         PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. INVESTORS SHOULD BE
         AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS
         INVESTMENT FOR AN INDEFINITE PERIOD OF TIME. THE ISSUER OF THESE
         SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE
         SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR
         RESALE IS IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE STATE
         SECURITIES LAWS.
    REGISTRATION RIGHTS. ALL SHARES OF WARRANT STOCK ISSUABLE UPON EXERCISE OF
THIS WARRANT SHALL BE "INVESTORS' REGISTRABLE SECURITIES" OR SUCH OTHER
DEFINITION OF SECURITIES ENTITLED TO REGISTRATION RIGHTS PURSUANT TO THE AMENDED
AND RESTATED INVESTORS' RIGHTS AGREEMENT, DATED AS OF THE DATE HEREOF, BY AND
AMONG THE COMPANY, THE HOLDER AND CERTAIN OTHER INVESTORS AS SET FORTH ON THE
SIGNATURE PAGES THERETO.
    FIDUCIARY DUTY. THE HOLDER SHALL BE THE BENEFICIARY OF THE SAME FIDUCIARY
DUTIES THAT MAY BE OWED BY THE MAJORITY SHAREHOLDER AND THE BOARD OF DIRECTORS
OF THE COMPANY, PURSUANT TO STATE AND FEDERAL LAW, TO HOLDERS OF THE COMMON
STOCK OF THE COMPANY.
    NOTICES. ALL NOTICES AND OTHER COMMUNICATIONS FROM THE COMPANY TO THE HOLDER
SHALL BE GIVEN IN ACCORDANCE WITH THE AGREEMENT.

                                       7
<PAGE>

    HEADINGS. THE HEADINGS IN THIS WARRANT ARE FOR PURPOSES OF CONVENIENCE IN
REFERENCE ONLY, AND SHALL NOT BE DEEMED TO CONSTITUTE A PART HEREOF.
    GOVERNING LAW. THIS WARRANT SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE
WITH, AND GOVERNED BY, THE LAWS OF THE STATE OF CALIFORNIA.
    NO IMPAIRMENT. THE COMPANY WILL NOT, BY AMENDMENT OF ITS ARTICLES OF
INCORPORATION OR BYLAWS, OR THROUGH REORGANIZATION, CONSOLIDATION, MERGER,
DISSOLUTION, ISSUE OR SALE OF SECURITIES, SALE OF ASSETS OR ANY OTHER VOLUNTARY
ACTION, AVOID OR SEEK TO AVOID THE OBSERVANCE OR PERFORMANCE OF ANY OF THE TERMS
OF THIS WARRANT, BUT WILL AT ALL TIMES IN GOOD FAITH ASSIST IN THE CARRYING OUT
OF ALL SUCH TERMS AND IN THE TAKING OF ALL SUCH ACTION AS MAY BE NECESSARY OR
APPROPRIATE IN ORDER TO PROTECT THE RIGHTS OF THE REGISTERED HOLDER OF THIS
WARRANT AGAINST IMPAIRMENT. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING,
THE COMPANY (A) WILL NOT INCREASE THE PAR VALUE OF ANY SHARES OF STOCK ISSUABLE
UPON THE EXERCISE OF THIS WARRANT ABOVE THE AMOUNT PAYABLE THEREFOR UPON SUCH
EXERCISE, AND (B) WILL TAKE ALL SUCH ACTION AS MAY BE NECESSARY OR APPROPRIATE
IN ORDER THAT THE COMPANY MAY VALIDLY AND LEGALLY ISSUE FULLY PAID AND
NON-ASSESSABLE SHARES OF COMMON STOCK UPON EXERCISE OF THIS WARRANT.
    NOTICES OF RECORD DATE.  IN CASE:
    the Company shall take a record of the holders of its Common Stock (or other
    stock or securities at the time receivable upon the exercise of this
    Warrant), for the purpose of entitling them to receive any dividend or other
    distribution, or any right to subscribe for or purchase any shares of stock
    of any class or any other securities or to receive any other right; or of
    any consolidation or merger of the Company with or into another corporation,
    any capital reorganization of the Company, any reclassification of the
    Common Stock of the Company, or any conveyance of all or substantially all
    of the assets of the Company to another corporation in which holders of the
    Company's stock are to receive stock, securities or property of another
    corporation; or of any voluntary dissolution, liquidation or winding-up of
    the Company; or of any redemption of all outstanding Common Stock; then, and
    in each such case, the Company will mail or cause to be mailed to the
    Registered Holder of this Warrant a notice specifying, as the case may be,
    (i) the date on which a record is to be taken for the purpose of such
    dividend, distribution or right, or (ii) the date on which such
    reorganization, reclassification, consolidation, merger, conveyance,
    dissolution, liquidation, winding-up, redemption or conversion is to take
    place, and the time, if any is to be fixed, as of which the holders of
    record of Common Stock or (such stock or securities as at the time are
    receivable upon the exercise of this Warrant), shall be entitled to exchange
    their shares of Common Stock (or such other stock or securities), for
    securities or other property deliverable upon such reorganization,
    reclassification, consolidation, merger, conveyance, dissolution,
    liquidation or winding-up. Such notice shall be delivered at least thirty
    (30) days prior to the date therein specified.
    SEVERABILITY. IF ANY TERM, PROVISION, COVENANT OR RESTRICTION OF THIS
WARRANT IS HELD BY A COURT OF COMPETENT JURISDICTION TO BE INVALID, VOID OR
UNENFORCEABLE, THE REMAINDER OF THE TERMS, PROVISIONS, COVENANTS AND
RESTRICTIONS OF THIS WARRANT SHALL REMAIN IN FULL FORCE AND EFFECT AND SHALL IN
NO WAY BE AFFECTED, IMPAIRED OR INVALIDATED.
    NO INCONSISTENT AGREEMENTS. THE COMPANY WILL NOT ON OR AFTER THE DATE OF
THIS WARRANT ENTER INTO ANY AGREEMENT WITH RESPECT TO ITS SECURITIES WHICH IS
INCONSISTENT WITH THE RIGHTS GRANTED TO THE HOLDERS OF THIS WARRANT OR OTHERWISE
CONFLICTS WITH THE PROVISIONS HEREOF. THE RIGHTS GRANTED TO THE HOLDERS
HEREUNDER DO NOT IN ANY WAY CONFLICT WITH AND ARE NOT INCONSISTENT WITH THE
RIGHTS GRANTED TO HOLDERS OF THE COMPANY'S SECURITIES UNDER ANY OTHER
AGREEMENTS, EXCEPT RIGHTS THAT HAVE BEEN WAIVED.
    SATURDAYS, SUNDAYS AND HOLIDAYS. IF THE EXPIRATION DATE FALLS ON A SATURDAY,
SUNDAY OR LEGAL HOLIDAY, THE EXPIRATION DATE SHALL AUTOMATICALLY BE EXTENDED
UNTIL 5:00 P.M. THE NEXT BUSINESS DAY.

                                       8
<PAGE>

         IN WITNESS WHEREOF, the parties hereto have executed this Warrant as of
the Effective Date.

THE PLASTIC SURGERY COMPANY, A GEORGIA CORPORATION

By:
         -----------------------------------------------------
Name:
         -----------------------------------------------------
Title:
         -----------------------------------------------------

[INSERT NAME OF LENDER]
By:
         -----------------------------------------------------
Name:
         -----------------------------------------------------
Title:
         -----------------------------------------------------

                            SIGNATURE PAGE TO WARRANT

                                       9
<PAGE>

                                    EXHIBIT 1

                               NOTICE OF EXERCISE

                    (To be executed upon exercise of Warrant)
The Plastic Surgery Company                                      WARRANT NO. ___
The undersigned hereby irrevocably elects to exercise the right of purchase
represented by the within Warrant Certificate for, and to purchase thereunder,
the securities of The Plastic Surgery Company as provided for therein, and
(check the applicable box):
|_| Tenders herewith payment of the exercise price in full in the form of cash
    or a certified or official bank check in same-day funds in the amount of
    $____________ for _________ such securities.
|_| Elects the Net Issue Exercise
    option pursuant to Section 2.2 of the Warrant, and accordingly requests
    delivery of a net of ______________ of such securities, according to the
    following calculation:
X        =        Y (A-B)  =        (____)         [(_____)   -(_____)]
                  -------
                              A                                          (_____)
         Where X = the number of shares of Common Stock to be issued to Holder.
         Y = the number of shares of Common Stock purchasable under the amount
             of the Warrant being exchanged (as adjusted to the date of such
             calculation).
         A = the Fair Market Value of one share of the Company's Common Stock.
         B = Purchase Price (as adjusted to the date of such calculation).

|_| Elects the Easy Sale Exercise option pursuant to Section 2.3 of the
    Warrant, and accordingly requests delivery of a net of ______________ of
    such securities. Please issue a certificate or certificates for such
    securities in the name of, and pay any cash for any fractional share to
    (please print name, address and social security number):
                  Name:
                       ------------------------------------------------
                  Address:
                          ---------------------------------------------
                  Signature:
                            -------------------------------------------

Note: The above signature should correspond exactly with the name on the first
page of this Warrant Certificate or with the name of the assignee appearing in
the assignment form below.

                                       10
<PAGE>

                                    EXHIBIT 2

                              NOTICE OF EXPIRATION
The Plastic Surgery Company                                      WARRANT NO. ___
Dated:
To __________________, the Holder of this Warrant:
You are hereby notified that the Warrant will expire on
___________________________ (the "Expiration Date"). The Expiration Date is
(check one):

(i)        The sixth (6th) anniversary of the payment in full of the note
      ---  issued together with the Warrant.

(ii)       The tenth (10th) anniversary of the date of issuance of the Warrant.
      ---
(iii)      Thirty (30) days after the date of delivery of this Notice (if later
      ---  than (i) and (ii) above.

                  In order to exercise the Warrant, you must comply with the
provisions of Section 2 thereof on or before the Expiration Date.

THE PLASTIC SURGERY COMPANY
By:
   -----------------------------------------
Name:
     ---------------------------------------
Title:
      --------------------------------------

                                       11
<PAGE>

                                    EXHIBIT 3

                                   ASSIGNMENT

          (To be executed only upon assignment of Warrant Certificate)

                                                                 WARRANT NO. ___

         For value received, _________________ hereby sells, assigns and
transfers unto _________________ the within Warrant Certificate, together with
all right, title and interest therein, and does hereby irrevocably constitute
and appoint __________________ ___________________ attorney, to transfer said
Warrant Certificate on the books of the within-named Company with respect to the
number of Warrants set forth below, with full power of substitution in the
premises:

<TABLE>
<CAPTION>
--------------------------------------- ------------------------------------ -------------------------------------
        NAME(S) OF ASSIGNEE(S)                        ADDRESS                           # OF WARRANTS
--------------------------------------- ------------------------------------ -------------------------------------

<S>                                     <C>                                  <C>
--------------------------------------- ------------------------------------ -------------------------------------

--------------------------------------- ------------------------------------ -------------------------------------

--------------------------------------- ------------------------------------ -------------------------------------

--------------------------------------- ------------------------------------ -------------------------------------
</TABLE>

And if said number of Warrants shall not be all the Warrants represented by the
Warrant Certificate, a new Warrant Certificate is to be issued in the name of
said undersigned for the balance remaining of the Warrants registered by said
Warrant Certificate.
Dated:
         ---------------------------
Signature:
          ----------------------------------------------------
Notice: The signature to the foregoing Assignment must correspond to the name as
written upon the face of this security in every particular, without alteration
or any change whatsoever; signature(s) must be guaranteed by an eligible
guarantor institution (banks, stock brokers, savings and loan associations and
credit unions with membership in an approved signature guarantee medallion
program) pursuant to Securities and Exchange Commission Rule 17Ad-15.

                                       12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00031-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00031-of-00352.parquet"}]]